About: Philippe Msellati

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Philippe Msellati Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher (ORCID 0000-0003-2568-1626)

Attributes	Values
rdf:type	Item
description	wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) researcher (ORCID 0000-0003-2568-1626) (en)
rdfs:label	Philippe Msellati (en) Philippe Msellati (nl)
skos:prefLabel	Philippe Msellati (en) Philippe Msellati (nl)
name	Philippe Msellati (en) Philippe Msellati (nl)
instance of	wds:Q91359173-BE4584AE-5547-463E-A41E-65670B2CC6DD
instance of	Homo sapiens
doctoral advisor	wds:Q91359173-5B3DDA88-319C-4680-A274-1702175C8D0F
doctoral advisor	Roger Salamon
occupation	wds:Q91359173-99FBE810-8111-4C07-920A-72824E31B90F
employer	wds:Q91359173-D0E535AE-95D1-4B4F-BA5F-93EC73825FA4
KBR person ID	wds:Q91359173-2744ADB9-E15E-4EC2-AAC0-C36C158C4531
sex or gender	wds:Q91359173-5475f4be-3472-48a9-9474-52f6db90a317
ISNI	wds:Q91359173-D619181D-4119-4B1F-B064-A2600D17C1D9
VIAF ID	wds:Q91359173-A083782E-42E3-4D22-88EF-224C98859F26
Bibliothèque nationale de France ID	wds:Q91359173-BE037F59-B7E0-4AA1-B457-BD8D5735BDDA
IdRef ID	wds:Q91359173-8E1E3389-1BD1-4468-95C1-C0C47C5FA92B
Persée author ID	wds:Q91359173-2D7ADFC6-2980-4B5C-86B4-3503085F4301
educated at	wds:Q91359173-8D1D4088-9A4E-482D-BFBE-AC5CCB9E2ED9 wds:Q91359173-E0552020-3A46-4348-8834-2672C9495B8E
VIAF ID	http://viaf.org/viaf/46974690
Bibliothèque nationale de France ID	http://data.bnf.fr/ark:/12148/cb14403722c#about
IdRef ID	http://www.idref.fr/060110252/id
Persée author ID	http://data.persee.fr/person/216778
occupation	researcher
employer	French National Research Institute for Sustainable Development
KBR person ID	14030003
sex or gender	male
ISNI	0000000010109414
VIAF ID	46974690
Bibliothèque nationale de France ID	14403722c
IdRef ID	060110252
Persée author ID	216778
educated at	Bordeaux Segalen University
ORCID iD	wds:Q91359173-EA88A4EB-7E41-4435-995F-D38A9109B3FE
ORCID iD	https://orcid.org/0000-0003-2568-1626
ORCID iD	0000-0003-2568-1626
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91359173
is author of	Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis Estimating incidence of HIV infection in childbearing age African women using serial prevalence data from antenatal clinics Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting Decrease of human immunodeficiency virus prevalence in antenatal clinics in Abidjan, Côte d'Ivoire, 1995-2002. Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa The unique features of pediatric HIV-1 in sub-Saharan Africa Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment Is the recommended dose of efavirenz optimal in young West African human immunodeficiency virus-infected children? Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'Ivoire Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study Perinatal transmission of HIV-1 Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Côte d'Ivoire Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire: ANRS 1278 study Primary HIV-1 infection in African children infected through breastfeeding Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children? Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17–20 February 1992 Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Seroincidence of HIV-1 infection in African women of reproductive age Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04 A cohort study of factors associated with failure to return for HIV post-test counselling in pregnant women Contextual or universal ethics: a non-issue? Viewpoint. Maternal HIV infection and infant feeding: support is the key. Are recommended doses of efavirenz optimal in young children? (ANRS 12103) Evolution of lipid levels in HIV-infected children treated or not with HAART in Abidjan, Cote d'Ivoire. Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children. HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278). Evolution of the biological follow-up of efficiency and tolerance of a once daily antiretroviral treatment with 3TC+DDI+EFV in children infected with HIV-1 (CLINICAL TRIAL ANRS 12 103) Once-a-day pediatric HAART with DDI+3TC+EFV in Burkina Faso. A phase II trial (ANRS 12103 trial) A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis Adherence in HIV-1 infected children taking once daily HAART with Didanosine + Lamivudine + Efavirenz in West Africa. ANRS 12103 clinical trial Didanosine population pharmacokinetics in West African HIV-infected children administered once daily tablets in relation to efficacy after one year of treatment (ANRS 12103)
is author of	wds:Q33336235-70D2927B-D38A-4DE9-B9B6-5CB35BD29E16 wds:Q34997616-D36AC13F-5EDF-4749-AEDA-D7D92A7F1573 wds:Q37392869-E84ABBE7-303F-4772-B811-9B3196FF81AD wds:Q44278299-2F042A25-AF40-44DF-81A9-9A6400C42582

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software